The International CAR T-cell therapy market is undergoing a period of rapid growth. This expansion can be attributed to several factors, including the growing prevalence of hematological malignancies, advances in biological therapies, and supportive regulatory sanctions. The market is classified by type of CAR T-cell therapy, application, level of